aTyr Pharma (FRA:471A) ROE % Adjusted to Book Value : -20.44% (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is aTyr Pharma ROE % Adjusted to Book Value?

aTyr Pharma's ROE % for the quarter that ended in Dec. 2024 was -90.95%. aTyr Pharma's PB Ratio for the quarter that ended in Dec. 2024 was 4.45. aTyr Pharma's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -20.44%.

aTyr Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for aTyr Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aTyr Pharma ROE % Adjusted to Book Value Chart

aTyr Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-43.18

-26.75

-62.06

-62.62

-18.32

aTyr Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-63.02	-44.03	-56.39	-46.19	-20.44

Competitive Comparison of aTyr Pharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, aTyr Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

aTyr Pharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, aTyr Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where aTyr Pharma's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

aTyr Pharma ROE % Adjusted to Book Value Calculation

aTyr Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-81.52%	/	4.45
	=	-18.32%

aTyr Pharma's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-90.95%	/	4.45
	=	-20.44%

aTyr Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of aTyr Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

aTyr Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » aTyr Pharma Inc (FRA:471A) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ATYR:USA

Address

10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121

Website

https://www.atyrpharma.com

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma Headlines

No Headlines